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Abstract.  The snRNP particles  include a  set of com- 
mon core snRNP proteins and snRNP specific pro- 
teins.  In rodent cells the common core proteins are the 
B, D, D',  E, F and G  proteins in a  suggested stoichi- 
ometry of BzD'2D2EFG. The additional U1- and U2- 
specific proteins are the 70-kD, A  and C  proteins and 
the £  and B" proteins,  respectively. Previous cell frac- 
tionation and kinetic analysis demonstrated the snRNP 
core proteins are stored in the cytoplasm in large par- 
tially assembled snRNA-free intermediates that as- 
semble with newly synthesized snRNAs during their 
transient appearance in the cytoplasm (Sauterer, 
R. A., R. J.  Feeney, and G. W.  Zieve.  1988.  Exp. 
Cell Res. 176:344-359).  This report investigates the 
assembly and intracellular distribution of the U1 and 
U2 snRNP-specific proteins.  Cell enucleation and 
aqueous cell fractionation are used to prepare nuclear 
and cytoplasmic fractions and the U1- and U2-specific 
proteins are identified by isotopic labeling and immu- 
noprecipitation or by immunoblotting with specific au- 
toimmune antisera.  The A, C, and/¢ proteins are 
found both assembled into mature nuclear snRNP par- 
ticles and in unassembled pools in the nucleus that ex- 
change with the assembled snRNP particles.  The unas- 
sembled proteins leak from isolated nuclei prepared by 
detergent extraction.  The unassembled £  protein sedi- 
ments at 4S-6S in structures that may be multimers. 
The 70-kD and B" proteins are fully assembled with 
snRNP particles which do not leak from isolated nu- 
clei. The kinetic studies suggest that the B" protein as- 
sembles with the U2 particle in the cytoplasm before 
it enters the nucleus. 
T 
HE snRNP particles are a family of ribonucleoprotein 
particles that contain an snRNA and from 6 to 10 pro- 
teins.  In the nucleus, the snRNP particles function in 
RNA processing, including  splicing and 3' end formation of 
pre-mRNA and rRNA maturation.  During the processing 
events, the snRNPs assemble into complexes with their sub- 
strates, which often include several different  snRNP parti- 
cles. Some of the snRNAs provide sequence specificity  by 
basepairing with conserved sequence motifs in their sub- 
strates  (for review,  see Maniatis  and  Reed,  1987; Sharp, 
1987; Steitz et al.,  1988;  Zieve and Sauterer,  1990). 
With limited exceptions,  the snRNP particles  have seven 
common proteins in addition to several snRNP-specific pro- 
teins.  The common core of snRNP protein in rodent cells 
consists of the B, D, D', E, F and G proteins in a suggested 
stoichiometry of B2D'2D2EFG. There are species and tissue 
specific variants of the B protein including a B' variant pres- 
ent in primate cells but not rodent cells and an N protein 
present in neuronal  tissue (Lelay-Taha et al.,  1986; Feeney 
et al., 1989; McAllister et al., 1989; Van Dam et al., 1989). 
The U1 snRNP has three specific proteins,  A, C, and 70-kD 
and the U2 snRNP has two,/¢ and B". This generates snRNP 
particles that are approximately 85 % protein.  (For review 
see Brunel et al., 1985; Reddy and Busch, 1988; Zieve and 
Sauterer,  1990.)  Autoimmune antisera  from patients  with 
systemic  lupus  erythematosus  (SLEy  recognize  both the 
common core proteins and the U1- and U2-specific proteins. 
The snRNAs are a family of stable 4-6S nuclear RNAs 
characterized by their unique 5' trimethylguanosine  caps and 
their transient  appearance in the cytoplasm immediately af- 
ter transcription.  The two most abundant snRNAs, U1 and 
U2, are present in ",,1  ×  106 copies per cell, the U3-U6 
snRNAs are 10-fold less abundant and the U7-U13 snRNAs 
are present in below 25,000 copies per cell nucleus (Reddy 
et al.,  1985;  Kramer,  1987; Montzka  and  Steitz,  1988). 
While in the cytoplasm the nucleoplasmic snRNAs assemble 
with the snRNP core proteins and undergo a variety of pro- 
cessing steps, including  hypermethylation  of the 5' cap and 
internal  nucleotides and 3' end processing (Eliceiri,  1974, 
1980; Madore et al., 1984; Zieve and Penman,  1976; Zieve 
et al.,  1988).  SnRNP core assembly is directed by a con- 
served sequence motif of PuA(U)nGPu (n >  3) present in a 
single stranded  region of the snRNA (for review see Parry, 
1988; Zieve and Feeney,  1989). 
SnRNP core proteins are present in the cytoplasm in large 
pools of partially assembled RNA-free intermediates.  The D, 
1. Abbreviations used in this paper: NLS, nuclear localization signal; SLE, 
systemic  lupus  erythromatosus~  SMEM,  suspension  minimal  essential 
medium. 
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D2EFG, which is the first intermediate to assemble with the 
snRNA followed by the D' and B protein. The B protein is 
present in the cytoplasm in a heterogeneous set of structures 
that may be homooligomers and the D' protein is present in 
20S  particles  (Fisher et al.,  1985;  Sauterer et al.,  1988, 
1990). Estimates from immunoblots ofcytoplasts and karyo- 
plasts obtained by enucleation of proliferating murine fibro- 
blasts indicate that the snRNP B protein is present in the 
cytoplasm in a 10-fold excess over the amount of snRNA un- 
dergoing processing and assembly (Sauterer et al.,  1988). 
The presence of large pools of snRNP core proteins in the 
cytoplasm is consistent with the observation that snRNA 
transcription and snRNP  particle assembly continues for 
over an hour after the inhibition of protein synthesis (Chan- 
drasekharappa et al.,  1983;  Zieve, 1987). 
In this report we describe the assembly and dynamic be- 
havior of the U1 and U2 snRNP-specific proteins. Cell enu- 
cleation allows the preparation of a bona fide cytoplasmic 
fraction uncontaminated by nuclear material.  These data 
suggest that in contrast to the snRNP core proteins, the U1 
and U2 snRNP-specific proteins are restricted to the nucleus. 
The Ul-specific A and C proteins and the U2-specific ,~ pro- 
tein are present in unassembled pools in the nucleus that ex- 
change with the mature snRNP particles and are prone to 
leak from nuclei prepared by aqueous cell fractionation. In 
contrast, the 70-kD and B" proteins are not found in unas- 
sembled pools.  The possible implications of this dynamic 
behavior for the functions of the mature snRNP particles in 
nuclear pre-mRNA processing are discussed. 
Materials and Methods 
Cell Culture and Labeling 
L929 mouse fibroblast cells and HeLa cells were grown in suspension cul- 
ture in minimal essential medium (SMEM; Gibco Laboratories, Grand Is- 
land, NY) supplemented with 5 % calf serum (Hyclone Laboratories, Lo- 
gan, UT) and 5% Serum Plus (Hazelton Biologicais, Lenexa, KS). Cells 
were maintained at a concentration between 4  x  105 and 6  x  105 cells per 
ml by daily feeding. 
For labeling times of 3 h or less, cells were concentrated to 5  x  106/ml 
in SMEM with reduced methionine, leacine, arginine, or phosphate content 
and  supplemented with  3  mM  glutamine  and  25  mM  Hepes,  pH  7.1. 
[35S]Methionine  (New England Nuclear, Boston, MA), [3H]leucine  (ICN 
Biomedicals, Irvine, CA), [3Hlarginine (ICN Biomedicals) and [32p]ortho- 
phosphate (ICN Biomedicals) are added as indicated. For labeling times of 
over 3 h, cells were labeled at a concentration of 5  x  105 cells/ml in me- 
dium with reduced methionine, leucine, or phosphate content as indicated. 
[3H]Uridine and [3H]adenosine (ICN Biomedicals) were added to the cul- 
tures in normal growth medium. 
For inhibitor treatments, cells were treated as described with 10 #g/ml 
Actinomycin D (Sigma Chemical Co., St. Louis, MO) from a 200x  stock 
in ethanol (Zieve, 1987). 
Cell Fractionation 
Aqueous cytoplasmic and nuclear fractions were obtained by a two step 
fractionation procedure (Feeney et al.,  1989).  Between 5  x  107 and l  × 
10  s cells were extracted in 1 ml cytoskeletal extract buffer (100 mM NaCI, 
10 mM Pipes, pH 6.8,  3 mM MgCl2, and 0.5%  Triton X-100)  with  1% 
aprotinin, 1 mM PMSE and 1 ug/ml leupeptin (all from Sigma Chemical 
Co.) and 2.5  mM yanodyl ribonucleoside complex (Berger and Birken- 
meirer, 1979) added to inhibit proteases and RNases, respectively. Nuclei 
and associated insoluble skeletal frameworks were pelleted by centrifuga- 
tion for 3 min at 2,000 g, and the supernatant was collected. The pellet was 
then extracted again in CSK buffer with 1% Tween 40 and 0.5% DOC and 
the nuclei were pelleted at 2,000 g for 3 min. The supernatants from the 
two extractions are pooled and represent the cytoplasmic fraction. This 
fraction is clarified by centrifugation at 5,000 g before use to remove any 
contaminating nuclei that are inadvertently picked up in the soluble frac- 
tions. Nuclear extracts are prepared for immunoprecipitation by extensive 
sonication of the residual pellet in l ml cytoskeletal extract, with inhibitors 
added, then clarified by centrifugation for 5 rain at 12,500 g in a microcen- 
trifuge. 
For experiments requiring bona fide cytoplasmic fractions, L929 cells were 
treated with 10 #g/ml cytochalasin B and eancleated in suspension on Ficoll 
gradients as previously described (Zieve et al., 1988).  Cytoplast fractions 
were solubilized by extraction in cytoskeletal extract buffer and insoluble 
cytoskeletal frameworks were removed by centrifugation at 2,000 g for 3 min. 
Antisera 
Hybridomas secreting mAbs of the anti-Sm and anti-(U1)RNP serotype 
were grown in culture and the tissue culture supematants, containing 2-4 
#g/ml IgG, were used for immunoprecipitations. The Y12 anti-Sm hybri- 
doma (Lerner et al.,  1981) was a gift of Dr. J. Steitz (Yale University) and 
recognizes primarily  the  B  protein on  immunoblots (Pettersson et al., 
1984),  whereas the (UI)RNP hybridoma that recognizes the 70-kD  UI- 
specific protein in immunoblots was the gift of Dr. S. Hoch (Agouron Insti- 
tute) (Billings et al.,  1982).  The human autoimmune (UI)RNP antiserum 
recognizes all three oftbe UI specific proteins, 70-kD, A and C in immuno- 
blots and was obtained from the Department of Pathology, SUNY Stony 
Brook. The human anti-U2 serum was a generous gift of Dr. J. Craft (Yale 
University) (Craft et at., 1988). The antiserum specifically immunoprecipi- 
tates the U2 snRNP and recognizes the ,~ and B" proteins in immunoblots 
of purified snRNP particles. However, the background in immunoblots of 
whole cell fractions obscures the U2-specific snRNP proteins. 
Irnmunoprecipitation  and Immunoblots 
0.1 mg preswelled  protein A-Sepharose (Sigma Chemical Co.) per immuno- 
precipitate was prebound for 24-72 h before use at 4"C with 5 ml of tissue 
culture supernatant or 15 #l patient serum, then was washed three times 
with CSK-ext just before use. Cell extracts or sucrose gradient fractions 
were added to the prebound antibodies and rotated at 4°C for 2-3 h. For 
analysis of the 70-kD U1 specific proteins, cell extracts were precleared by 
mock immunoprecipitation with protein-A Sepharose bound to a  mouse 
mAb to a Drosophila-specific nuclear envelope antigen, which was the gen- 
erous gift of Dr. E  Fisher (SUNY Stony Brook). This significantly reduces 
the background in the high-molecular weight region. 
After incubation with antibodies, samples were washed five times in NP- 
40 IP wash (150 mM NaCl, 10 mM Tris-HC1, pH 7.5, and 1% NP-40). Sam- 
ples were transferred to new Eppendorf tubes at the end of the second wash 
to eliminate proteins nonspecifically  adsorbed to the walls of the tube. After 
the washes, the pellets were rinsed in IP wash without detergents and the 
samples were drained and boiled in protein sample buffer. 
For immunoblots, proteins were transferred from polyacrylamide gels to 
nitrocellulose by electrophoresis at  15 V/cm for 4 h in 25 mM Tris,  192 
mM glycine, 20% methanol. Nitrocellulose was then blocked by incubation 
in 1% nonfat dried milk in TBS (5 mM Tris pH 7.4,  150 mM NaCl), then 
rinsed three times in TBS 0.2% Tween 20 for 30 min, then air dried and 
maintained at 4°C until needed. For analysis, nitrocellulose strips were in- 
cubated with antisera, either tissue culture supernatant containing mouse 
mAbs or a 1/100 dilution of patient serum with TBS, for 1 h at 37"C. Strips 
were then rinsed extensively in 0.2% Tween 20 in TBS and incubated in 
a  second antibody (either goat anti-mouse IgG or goat anti-human IgG) 
conjugated to alkaline phosphatase (Boehringer Mannheim Biochemicals, 
Indianapolis, IN) for I h at 37°C. After extensive rinsing, strips were devel- 
oped with 0.2 mg/ml p-NBT chloride and 0.2 mg/mi 5-bromo-4-chloro-3- 
indoyl phosphate (U.S. Biochemical Corp., Cleveland, OH) in  100 mM 
Tris, pH 9.7. 
Electrophoresis 
Electrophoretic analysis of proteins in one dimension used either 13 or 
6-12%  acrylamide running gels as previously described (Feeney et al., 
1989).  TCA precipitated cell fractions or immunoprecipitates were boiled 
in protein sample buffer (2% SDS, 10% glycerol, 100 mM DTT,  80 mM 
Tris-HC1,  pH 6.8, 2 mM EDTA, and 0.01% bromphenol blue) and run for 
1050 V-h. Two-dimensional gel eleetrophoresis using NEPHGE was per- 
formed as previously described (Feen~ et at.,  1989). 
RNAs were analyzed using 6-15% nondenaturing gradient gels (Zieve 
and Penman, 1976).  RNA samples in sample buffer (50 mM Tris-HC1,  pH 
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cyanol) were run for 1200 V-h. 
Gels were then treated with Enhance (New England Nuclear,  Boston, 
MA) according to product instructions and vacuum dried for fluorography 
using preflasbed  X-Omat AR film (Eastman Kodak Co., Rochester,  NY). 
Typical exposures were from 2 to 10 d. Scanning and quantitation  of fluom- 
graphs were performed using an LKB Ultrosean (LKB Instruments, Galth- 
ersburg, MD) and associated software for an IBM XT computer. Autoradio- 
graphic images were maintained between 0.4 and 2.50.D. units, within the 
linear range of the x-ray film and laser densitometer. 
Results 
Identification of U1 and U2 snRNP-specific Proteins 
In addition to the snRNP core proteins shared by all the nu- 
cleoplasmic snRNP particles, there are snRNP-specific pro- 
teins. The specific proteins of the U1 and U2 snRNP parti- 
cles, the two most abundant snRNP particles, are the A, C, 
and 70-kD proteins and the b/and B" proteins, respectively. 
The cDNAs of all the U1 and U2 specific snRNP proteins 
are cloned and sequenced and autoimmune sera are available 
that specifically recognize these proteins (Thiessen et al., 
1986; Habets et al., 1987; Sillekens et al., 1987; Yamamoto 
et al.,  1988;  Sillekens  et al.,  1988;  Query et  al.,  1989; 
Fresco and Keene, 1989).  Fig. 1 shows the profile of immu- 
noprecipitated  snRNP  particles  labeled  with  [3H]leucine, 
[3~S]methionine, [~H]arginine, or [32P]orthophosphate.  Len- 
cine labeling is best for identifying the U2 specific ,~ protein 
because sequence data indicate it is low in methionine; how- 
ever,  the Ul-specific C  protein is low in leucine. The U1- 
specific 70-kD protein is especially rich in arginine and is 
the only snRNP phosphoprotein. 
The Sm antiserum found in patients with SLE recognizes 
the common core snRNP proteins and with limited excep- 
tions, immunoprecipitates the entire family of snRNP parti- 
cles including U1 and U2 (Fig. 1, lanes 2, 3, and 5). The B, 
D, E, E and G snRNP core proteins all label with either leu- 
cine, methionine or arginine and the B and D core proteins 
are the most heavily labeled proteins in Sm immunoprecipi- 
tates. The D snRNP protein can be resolved into a pair of 
closely spaced D and D' proteins in gels containing urea, 
however in this system they migrate as one wide band and 
are labeled as D (Bringmann and Luhrmann, 1986; J. Ander- 
sen, R. J. Feeney, and G. W. Zieve, manuscript in prepara- 
tion). In addition, the E and F proteins often comigrate in 
this gel system. The Ul-specific 70-kD, A, and C proteins 
and the U2-specific/¢ and B" proteins are identifiable in the 
Sm immunoprecipitates and this demonstrates they are as- 
sembled into snRNP particles with the snRNP core proteins. 
The A  and C  and B" proteins label well with methionine 
(lanes 3 and 4), the A, A', and B" proteins label well with 
leucine (lanes 1 and 2) and the 70-kD protein labels espe- 
ciaUy well with arginine (lanes 5 and 6). The 70-kD protein 
is the only major snRNP protein that is phosphorylated (lane 
7). The specific proteins of the less abundant snRNP parti- 
cles are not identifiable in these preparations at this level of 
resolution. The availability of specific antisera to the U1 and 
U2 proteins and two-dimensional gel electrophoresis helps 
confirm the identities of the U1- and U2-specific proteins. 
Immunoprecipitates of leucine-labeled cell extracts with a 
U2 specific serum specifically precipitates the ~/and B" U2 
specific proteins along with the core snRNP proteins (lane 
1, Mimori et al., 1984; Craft et al., 1988).  The mobility of 
Figure 1. Immunoprecipitation of snRNP proteins with SLE au- 
toimmune antisera. L929 cells were labeled with either [3H]leu- 
cine (lanes I and 2), [35S]methionine  (lanes 3 and 4), [3H]arginine 
(lanes 5 and 6), or [32p]orthophosphate (lane 7). HeLa cells were 
labeled with [35S]methionine (lane 8) as described in Materials 
and Methods and nuclear fractions were immunoprecipitated  with 
the YI2 anti-Sm monoclonal antisera (lanes 2, 3, and 5), the anti- 
U2 autoimmune antiserum (lane 1) or the 70-kD-specific anti-U1 
(RNP) monoclonal antisera (lanes 4, 6,  7, and 8). 
the U2-specific protein B  # is slightly slower than the B pro- 
tein. This is also the mobility of the B' core protein found 
in primate cells, which is closely related to the B protein and 
may differ by either post translational modification or differ- 
ential RNA splicing (Reuter et al.,  1987; Van Dam et al., 
1989). The B' core protein is visible in the Ul-specific immu- 
noprecipitates of the human HeLa cell line (lane 8).  How- 
ever, the B' core protein is absent in rodent cells. This is seen 
in the two-dimensional gels in Fig. 2. In HeLa cells the B 
protein is a closely spaced doublet with the 1-kD larger pro- 
tein designated as B' (Fig. 2,  C and D).  The B' protein is 
missing in the rodent cells and therefore the B" protein can 
be analyzed directly on one-dimensional gels (Fig. 2, A and 
B). The B" protein is more acidic than the B and B' proteins 
and is separated from them in two-dimensional gels (Fig. 2, 
B and D). The U2-specific ~  protein has only 2 methionines 
but over 30 leucines and is easily identified in one- or two- 
dimensional gels of cells labeled with [3H]leucine (Fig. 2 C). 
The Ul-specific A and C proteins are easily identifiable in 
immunoprecipitates with either Sm- or Ul-specific sera of 
methionine labeled extracts (Fig. 1, lanes 3 and 4). They are 
basic proteins with pI's similar to that of the B and D core 
proteins. The 70-kD Ul-specific protein is difficult to iden- 
tify in methionine-labeled cells because of the high back- 
ground in the 70-kD region, but is readily apparent in cells 
labeled with either arginine or phosphate (Fig. 1, lanes 5, 6, 
and 7). The yields of the snRNP core proteins are occasion- 
ally low in immunoprecipitates with the 70-kD-specific anti- 
(U1)RNP monoclonal antiserum, which suggests the associ- 
ation of the 70-kD  protein  with the  U1  particles  can be 
disrupted during immunoprecipitation (lane 6). 
The 70-kD protein is the only snRNP protein that is phos- 
Feeney and Zieve Localization  of U1 and U2 snRNP-specific Proteins  873 Figure 2. Identification of  the U1 and U2 snRNP proteins in two-dimensional gel electrophoresis. (A) Immunoprecipitate with the (UI)RNP 
human antiserum of nuclear extracts of L929 cells labeled for 16 h in 80% methionine-free SMEM with 5 #Ci/ml  [35S]methionine  ana- 
lyzed by nonequilibrium two-dimensional gel electrophoresis as described in Materials and Methods. In this and all other two-dimensional 
gels, the basic side of the gel is on the right and arrowheads mark the identified snRNP proteins. (B) Immunopreeipitate with the anti-Sm 
Y12 mAb of nuclear extracts of L929 cells labeled for 16 h in 80% methionine-free SMEM with 5 tLCi/ml psS]methionine analyzed by 
nonequilibrium two-dimensional eleetrophoresis as described in Materials and Methods. (C) Immunoprecipitate with the anti-U2 human 
serum of nuclear extracts of HeLa cells labeled for 16 h in 80% leucine-free SMEM with 10 tLCilml [3H]leucine analyzed by nonequi- 
librium two-dimensional electrophoresis as described in Materials and Methods. (D) Immunoprecipitates using the anti-Sm YI2 antibody 
of nuclear extracts of HeLa cells labeled for 16 h in 80% methionine-free SMEM with 5 #Ci/ml [3SS]methionine  were analyzed by non- 
equilibrium two-dimensional electrophoresis as described in Materials and Methods. 
phorylated and it is clearly identifiable in immunoprecipi- 
tates of  phosphate labeled cells (lane 7; Wooley et al., 1983). 
There is a phosphoprotein of •50  kD in the UI(RNP) immu- 
noprecipitates of  unknown origins. The identity of  the 70-kD 
phosphorylated protein is confirmed by immunoblotting of 
phosphate  labeled  immunoprecipitates  with  a  70-kD-spe- 
cific mAb (Billings et al., 1982; Fig. 3). Because the immu- 
noprecipitates and the immunoblots used mouse monoclonal 
antisera the alkaline phosphatase-coupled anti-mouse anti- 
body used as a  second antibody in  the immunoblots also 
recognized the IgG heavy and light chain present in the im- 
munoprecipitates.  The  70-kD  Ul-specific  phosphoprotein 
is immunoprecipitated in the nucleus by both the Sm and 
UI(RNP) antisera, demonstrating it is assembled into snRNP 
particles (Fig. 3, lanes 1 and 3). As will be discussed later, 
the 70-kD protein is absent from cytoplasmic fractions (Fig. 
3, lane 2). 
The phosphate-labeled 70-kD protein provides a marker 
to identify the 70-kD protein in cells labeled with amino 
acids.  Because of the large number of nonspecific proteins 
immunoprecipitated in the 70-kD region by either the Sm or 
UI(RNP) antisera, it is necessary to preclear nuclear extracts 
by a mock immunoprecipitation with a nonspecific antibody 
to reduce the background to help identify the 70-kD Ul-spe- 
cific protein. The 70-kD protein is ,,020 % arginine and is es- 
pecially well labeled with [3H]arginine (Fig.  1, lanes 5 and 
6). The methionine-labeled 70-kD protein is more highly la- 
beled in UI(RNP) immunoprecipitates of HeLa cells than in 
L929 cells, where it is still difficult to identify in one-dimen- 
sional gels even after preclearing (lanes 4 and 8). An immu- 
noprecipitation of the arginine-labeled nuclear extract with 
the monoclonal antisera to the 70-kD protein identifies a 
large amount of the 70-kD protein in the L929 cells but very 
few snRNP core particles (lane 6). This suggests that the U1 
particles were disrupted during the immunoprecipitation or 
that there is a significant fraction of the 70-kD protein not 
assembled into snRNP particles. 
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L929  cells  were  labeled  for 3  h  with  50  /~Ci/ml 32P  in 95% 
phosphate-free SMEM then fractionated into cytoplasm (lane 2 and 
5) and nucleus (lane 1, 3, 4, and 6) by aqueous cell fractionation. 
Fractions were immunoprecipitated  with the Y12 anti-Sm (lane I) 
or anti(Ul)RNP  monoclonal antisera (lanes 2 and 3) and analyzed 
by gel electrophoresis  and then transferred  to nitrocellulose.  The 
blot was then probed with the anti-(Ul)RNP  monoclonal antisera 
(lanes 4, 5, and 6) and the immunoblot was exposed to film to iden- 
tify the immunoprecipitated  radiolabeled  70-kD protein (lanes 1, 
2, and 3). The IgG heavy chain (HC, 50,000 kD) and light chain 
(LC, "~25,000 kD) in the immunoprecipitates  is recognized by the 
alkaline  phosphatase-coupled  goat-anti-mouse immunoglobulin 
used as a second antibody  in the immunoblots. 
lntraceUular Distribution of the 
snRNP-specific Proteins 
Previous cell fractionation studies using cell enucleation to 
prepare bona fide cytoplasmic fractions identified large pools 
of the snRNP core proteins stored in the cytoplasm of the 
L929 cells (Sauterer et al.,  1988). Because of the high abun- 
dance of the snRNP proteins in the nucleus,  it was neces- 
sary to eliminate the possibility of nuclear leakage during 
aqueous cell fractionation. In Figs. 4 and 5 the intracellular 
distribution of the U1- and U2-specific snRNP proteins is in- 
vestigated using both cell enucleation and aqueous cell frac- 
tionation. The snRNP proteins are identified by both immu- 
noprecipitation (Fig.  4) and immunoblotting (Fig.  5).  The 
data suggest that in contrast to the snRNP core proteins, the 
U1- and U2-specific proteins are all localized in the nucleus 
however the dynamic behavior varies. The A, C, and ,~ pro- 
teins, but not the B" and 70-kD proteins, are present in large 
unassembled pools that are prone to leak from nuclei gener- 
ated by aqueous cell fractionation. 
In Fig.  4  aqueous cytoplasmic fractions (lanes 1  and 2) 
and cytoplast fractions prepared by cell enucleation (lanes 3 
and 4) are immunoprecipitated with anti-Sm (lanes 2 and 4) 
and anti-(U1)RNP (A, lanes 1 and 3) and anti-U2 (B,  lanes 
1 and 3) sera. Cells are labeled with [35S]methionine  for the 
analysis of the U1  specific proteins (A)and  pH]leucine for 
the U2-specific proteins (B). The anti-Sm sera immunopre- 
cipitates the full set of core proteins from both the aqueous 
cytoplasm and cytoplast fraction (A and B, lanes 2  and 4). 
The signal is lower from the cytoplasts because this fraction 
Figure 4.  Distribution  of the UI and U2 snRNP-specific proteins 
by immunoprecipitation  in cytoplasmic fractions prepared by both 
aqueous  fractionation  and cell  enucleation.  5  ×  107 L929  cells 
were labeled for 30 rain with 80/~Ci/ml  [35S]methionine in 100% 
methionine-free  medium (A)  or with  80  /~Ci/ml [~H]leucine in 
100 % leucine-free medium (B). Half  the ceils were enucleated and 
half were fractionated by aqueous cell fractionation. Aqueous cyto- 
plasm (lanes 1 and 2) and cytoplast fractions (lanes 3 and 4) were 
immunoprecipitated with the Y12 anti-Sin monoclonal antisera (A 
and B, lanes 2 and 4) or the anti-(U1)RNP human serum (A, lanes 
1 and 3) or the anti-U2 human serum (B, lanes 1 and 3). 
Figure 5.  Distribution of the Ul-specific proteins in bona fide nu- 
clear and  cytoplasmic  fractions  by immunoblotting.  L929  cells 
were enucleated and cytoplast and karyoplast fractions were immu- 
noblotted with the anti-(Ul)RNP mAb (,4) or the anti-(U1)RNP hu- 
man serum (B). (,4) Cytoplasts  (lane 1) and karyoplasts (lane 2) 
from 5  x  106 L929 cells were analyzed on 6-12%  gradient  gels 
and immunobloRed with the anti-(U1)RNP monoclonal antiserum 
that recognizes the 70-kD Ul-specific protein.  (B) 2  x  107 cyto- 
plasts (lane 1) and 2.5  x  106 (lane 2), 5  x  106 (lane 3), and 1 x 
107  karyoplasts  (lane  4)  were  immunoblotted  with  the  anti- 
(U1)RNP human serum that recognizes the A, C, and 70-kD U1- 
specific proteins. 
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sera immunoprecipitates the A and C proteins from an aque- 
ous cytoplasm (A, lane 1), they are totally absent from a cy- 
toplast fraction (A, lane 3). The anti-Sm antiserum also im- 
munoprecipitates the Ul-specific A and C protein from the 
aqueous cytoplasm (lane 2) but not the cytoplast fraction 
(lane 4). Recognition of the Ul-specific A and C proteins by 
anti-Sm sera has been reported previously and the A protein 
has been suggested to contain an Sm epitope (Silleke.ns et 
al.,  1987; Sauterer et al.,  1990). 
Similarly to the Ul-specific A and C proteins the ,~ protein 
which is precipitated by the anti-U2 sera from an aqueous 
cytoplasm (B, lane I) is totally lacking from a cytoplast frac- 
tion (B, lane 3).  Substantial amounts of the U2-specific B" 
protein and the Ul-specific 70-kD protein are found only in 
nuclear fractions (Fig. 3; Feeney et al.,  1989).  These data 
suggest that the A, C, and ,g proteins appear in the aqueous 
cytoplasm because they leak from the isolated nuclei. This 
localization is also confirmed by immunoblotting. 
In Fig. 5, cytoplast and karyoplast fractions are immuno- 
blotted with the Ul-specific mAb and human autoimmune 
sera.  The  mAb  is  specific  for  the  70-kD  protein  and  it 
identifies the 70-kD protein only in the nuclear fraction (A, 
lanes I  and 2). Aqueous cell fractiouation and immunopre- 
cipitation with the 70-kD specific mAb also identifies the 
phosphate labeled 70-kD protein only in the nuclear fraction 
(Fig. 3, lanes 2 and 3), indicating that it does not leak from 
isolated nuclei. The human autoimmune serum that recog- 
nizes all three of the U1 specific proteins was also immuno- 
blotted against karyoplast and cytoplast fractions to evaluate 
the distribution of the A, C, and 70-kD proteins (Fig. 5 B). 
Immunoblotting of dilutions of the karyoplast fraction indi- 
cate that the intensity of the immunoblot reaction is linearly 
related to the abundance of the individual proteins (Fig. 5 B, 
lanes  2-4).  Although there  are  some  nonspecific bands 
identified in the region of A and C, the immunoblots fail to 
identify the A, C, or 70-kD Ul-specific snRNP proteins in 
the cytoplast fractions. This suggests that all the U1 specific 
snRNP proteins are restricted to the nucleus in vivo and that 
the A and C proteins, but not the 70-kD protein, leak from 
nuclei prepared by aqueous cell fractionation. Analogous ex- 
periments with the U2-specific autoimmune serum were not 
successful. Although the U2 serum specifically immunopre- 
cipitates the U2 snRNP and recognizes the U2-specific pro- 
teins in immunoblots of purified snRNPs,  the nonspecific 
background in immunoblots of whole cell fractions obscures 
the U2-specific proteins. 
Sedimentation Distribution of  the 
U2-specific A' Protein 
The sedimentation distribution of the A and C  Ul-specific 
proteins that leak from isolated nuclei was evaluated in a 
previous report (Sauterer et al.,  1990).  The C protein sedi- 
ments at •6S  and the A protein at 18-20S.  Neither of the 
proteins that leak into the cytoplasm is assembled with 11- 
15S snRNP particles. In Fig. 6 the sedimentation distribu- 
tion of the ~ protein that leaks from the nucleus was investi- 
gated by sucrose gradient sedimentation. 
L929 cells were pulse-labeled for 2 h with [3H]leucine to 
label the A¢ protein and aqueous cytoplasmic fractions were 
resolved by sucrose gradient sedimentation. Parallel gradi- 
ents were im'munoprecipitated with the anti-Sm monoclonal 
Figure 6. Sedimentation distribution of the g  protein in the cyto- 
plasm. 2  x  l0  s L929 cells were labeled for 2 h in 95% leucine- 
free SMEM with 80 #Ci/ml  [3H]leucine. Cytoplasmic fractions 
were fractionated on 7.5-25% sucrose gradients and the gradient 
fractions and the pellet (P) were immunoprecipitated  with the anti- 
Sm mAb Y12 (A) or the anti-U2 human serum (B) as described in 
Materials and Methods. Locations of the marker proteins from par- 
allel gradients is indicated. 
antiserum that recognizes the snRNP core proteins, and the 
anti-U2  antiserum.  The  immunoprecipitated snRNP  core 
proteins have the characteristic sedimentation distribution 
reported earlier (Sauterer et al.,  1990).  The newly synthe- 
sized B protein sediments from 4-20S, D protein sediments 
at 6 and 20S and the E, F, and G proteins are at 6S. A faint 
amount of the ,~ protein is immunoprecipitated by the Sm 
antiserum in the 11-15S region of the gradient where fully 
assembled mature snRNP particles sediment. The precipita- 
tion of/¢ by the anti-Sm sera indicates the/( protein in the 
11-15S structures is assembled into snRNP particles that are 
either  newly assembled  in  the  cytoplasm or  which  have 
leaked from the nucleus during cell fractionation. 
In contrast to the sedimentation of Sm precipitated pro- 
teins, the g  protein precipitated by anti-U2 sera sediments 
primarily at 4-8S (B). This is distinct from the 11-15S as- 
sembled snRNP particles and suggests that the ~¢ that leaks 
into the cytoplasmic fraction is not assembled into snRNPs. 
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in the 4-8S structures is eluted from the U2 snRNP particles 
during cell fractionation. Small amounts of the immunopre- 
cipitated ,g protein are in structures of 11S and larger, which 
include protein assembled into snRNP particles as observed 
previously in the Sm immunoprecipitates. No U2-specific B" 
protein is seen in the cytoplasmic fractions, which is consis- 
tent with the cell fractionation data that show it is localized 
in the nucleus and does not leak from isolated nuclei. 
Assembly Kinetics of the U1 and U2 
snRNP-specific Proteins 
To determine if the  U2-specific proteins  require de novo 
snRNP particle assembly to enter the nucleus, the nuclear 
accumulation of newly synthesized ,~ and B" proteins was 
monitored in the presence and absence of snRNP assembly. 
SnRNP particle assembly was halted by pretreating the L929 
cells with actinomycin D to arrest snRNA synthesis. Preex- 
isting snRNAs assemble into snRNPs in the cytoplasm and 
move into the nucleus with a half-life of ~  20 rain and this 
results in ceils with no snRNPs assembling in the cytoplasm 
(Zieve,  1987;  Feeney et al.,  1989).  In Fig.  7, cytoplasmic 
and  nuclear  fractions  of  [aH]leucine-labeled control  and 
actinomycin D-treated  cells  are  immunoprecipitated  with 
both anti-Sm and anti-U2 sera after a pulse label and after 
a chase. The Sm antisera will identify the U2-specific pro- 
tein only if they are assembled into mature snRNP particles 
and the U2-specific serum immunoprecipitates both assem- 
bled and unassembled ,~ and B" proteins. 
In the control cells immunoprecipitated with anti-Sm sera, 
large amounts of snRNP core proteins are immunoprecipi- 
tated from cytoplasmic fractions (Fig. 7 A, lanes 1 and 3) 
and the movement of the snRNP core proteins into the nu- 
clear  fraction,  indicative  of de  novo  snRNP  particle  as- 
sembly, is observed after a chase (Fig. 7 A, lane 4). The A, 
A', and B" proteins are also precipitated from the chased nu- 
clear fractions indicating that assembled U1 and U2 snRNPs 
develop during the chase.  With prior actinomycin D  treat- 
ment, the movement of the snRNP core proteins into the nu- 
cleus is halted (Fig. 7 A, lane 8). However, the U1- and U2- 
specific A, A', and B" proteins still appear in mature nuclear 
snRNPs  (Fig.  7  A,  lane  8).  The  immunoprecipitation of 
these proteins in the nucleus by the Sm antiserum in the pres- 
ence of actinomycin D suggests that they enter the nucleus 
independently of cytoplasmic snRNP  assembly and  asso- 
ciate with preexisting U1  and U2 snRNP particles. 
Immunoprecipitation of an identical set of cell fractions 
with the U2-specific antisera identifes both the assembled 
and unassembled pools of  the U2-specific proteins. Immuno- 
precipitation  of  cytoplasmic  and  nuclear  fractions  from 
pulse and chased control cells with U2-specific antiserum 
identifies a  large pool of ,g protein in the cytoplasm and 
"~15 % of the total immunoprecipitated A~ protein appears in 
the nuclear fraction during a chase (Fig. 7 B, lane 4). The 
actinomycin D  pretreatment  blocks  the  movement of the 
snRNP core proteins into the nucleus as expected but it has 
no effect on the distribution of the ,~ protein (Fig. 7 B, lane 
8). The results discussed above suggest that the 85 % of the 
pulse-labeled/( protein immunoprecipitated from the cyto- 
plasmic fraction is in a form that has leaked out of the nuclei 
during the detergent fractionation. The inability to immuno- 
precipitate the majority of  this protein with the Sm antiserum 
Figure 7. Nuclear accumulation of the U2-specific ,~ protein does 
not require snRNP assembly. 1.5  x  l0  s L929 cells were labeled 
for 30 min in 100% leucine-free SMEM with 100/zCi/ml [3H]leu- 
cine (lanes 1, 2, 5, and 6) and chased in normal SMEM (lanes 3, 
4, 7, and 8) for 90 min. Lanes 1-4 are controls and lanes 5-8 are 
cells pretreated with 10/zg/ml actinomycin D for 30 min before la- 
beling. Cells were fractionated into aqueous cytoplasm (1, 3, 5, and 
7) and nucleus (2, 4, 6, and 8) and immunoprecipitated with either 
the anti-Sm Y12 mAb (A) or the anti-U2 human autoimmune serum 
(B) as described in Materials and Methods. 
indicates it is not assembled into snRNP particles (Fig. 7 A, 
lanes 1, 3, 5, and 7). This suggests the majority of the newly 
synthesized protein is not assembled with the U2 snRNPs in 
the nucleus and is free to leak from the nucleus during cell 
fractionation. Alternatively, this ,~ protein is stripped from 
the U2 snRNP particles by the extraction conditions. This 
seems less likely because the U2 snRNPs are stable under 
more stringent buffer conditions containing up  to 0.5  M 
NaCI. It is difficult to identify the U2-specific B" protein in 
the immunoprecipitates with the U2-specific serum. 
The observation that the arrest of snRNP assembly by de- 
pletion of  the snRNAs does not halt the nuclear accumulation 
of the U2-specific ~¢ or B" proteins suggests these proteins 
can move into the nucleus independently and enter a pool of 
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previous experiments, it was demonstrated that the U1 A and 
C  proteins show a  similar behavior (Feeney et al.,  1989). 
However, it does not determine whether the newly assem- 
bled snRNP particles in the cytoplasm can bind newly trans- 
lated  snRNP-specific protein  in  the cytoplasm before en- 
tering the nucleus or whether assembly occurs only after the 
particles enter the nucleus. 
To determine if the snRNP-specific proteins can assemble 
with newly formed snRNPs in the cytoplasm, newly synthe- 
sized snRNAs were immunoprecipitated from bona fide cy- 
toplasmic fractions by the specific antisera. In Fig. 8, pulse- 
labeled snRNAs were immunoprecipitated from cytoplasts 
with specific antisera. The anti-Sm sera precipitates the ma- 
jor snRNAs as expected because snRNP core assembly oc- 
curs in the cytoplasm (lane 2). The U2 snRNP is also precip- 
itated by the anti-U2 serum (lane 4) but U1  snRNA in the 
cytoplasm is not precipitated with the anti-70-kD mAb (lane 
3). No U1 snRNA was detected in the (U1)RNP immunopre- 
cipitates  even  in  exposures  where  the  other  lanes  were 
significantly overexposed. This suggests that indeed some of 
the U2-specific proteins do assemble into snRNP particles 
in the cytoplasm but not the Ul-specific 70-kD protein. To 
investigate the possible assembly of the U2-specific proteins 
with the U2 snRNP particles in the cytoplasm, the sedimen- 
tation distribution  of snRNP  proteins was  investigated in 
bona fide cytoplasmic fractions generated by cell enucle- 
ation (Fig. 9). The snRNP core proteins exhibit the sedimen- 
tation distribution described previously (Fig. 6).  However, 
Figure 9. Sedimentation distribution of U2-specific  B"  protein in as- 
sembled snRNP particles in cytoplasts. 2  ×  10  s L929 cells were 
labeled for 1 h in 95% methionine-free SMEM with 100 #Ci/ml 
[3SS]methionine. Cells  were enucleated and the cytoplasts were 
extracted with cytoskeletal extract buffer and 0.5 % Triton-X-100  as 
described in Materials and Methods and the detergent soluble frac- 
tions were analyzed by sucrose gradient sedimentation as described 
in the legend to Fig. 6. The gradient fractions were immunoprecipi- 
tated with YI2 anti-Sm monoclonal antiserum. 
a  small amount of the U2-specific B" protein, but not the 
other U1 or U2 specific proteins, is found sedimenting in the 
11-13S region where assembled U2 snRNP particles sedi- 
ment (Sauterer et al.,  1990). This strongly suggests that the 
B ~  protein can assemble with the U2 snRNP particles while 
they are in the cytoplasm. 
Figure 8.  SnRNP assembly  in the  cytoplasm.  7.5  x  107 L929 
cells were pulse-labeled for 45 min with 100 #Ci/ml  [3H]uridine 
and 100 #Ci/ml  [3H]adenosine  in normal SMEM and enucleated 
as described in Materials and Methods. The cytoplast fraction was 
extracted in CSK-ext and the solubilized cytoplasm was immuno- 
precipitated with the anti-Sm monoclonal antisera (lane 2), anti- 
(UI)RNP monoclonal antisera (lane 3), and anti-U2 human sera 
(lane 4). Marker RNA of a total cytoplasmic fraction is illustrated 
in lane 1. RNA gel electrophoresis was performed as previously de- 
scribed. 
Discussion 
With limited exceptions, snRNP particles share a common 
core of proteins, with the snRNA component and several 
specific proteins differing in the individual snRNP particles. 
In this report we use autoimmune antisera that recognize the 
snRNP core proteins and the U1 and U2 snRNP-specific pro- 
teins to analyze the synthesis and assembly of the U1 and U2 
snRNP particles. Cell fractionation by cell enucleation, to 
eliminate nuclear leakage, and by conventional aqueous ex- 
traction demonstrate that in contrast to the snRNP core pro- 
teins, present in snRNA-free pools in the cytoplasm, the U1 
and U2 snRNP-specific proteins are localized almost quanti- 
tatively in the interphase nucleus. The three Ul-specific pro- 
teins, A, C, and 70-kD, and the U2-specific g  and B" pro- 
teins, display two types of  behavior. The A, C, and g  snRNP 
proteins are present both assembled into snRNP particles 
and in unassembled pools in the nucleus while the W and 70- 
kD snRNP proteins are present only in assembled snRNP 
particles (Fig. 10). The unassembled pools of the A, C, and 
.g proteins leak from isolated nuclei prepared by detergent 
extraction procedures but are absent from bona fide cyto- 
plasmic fractions prepared by cell enucleation. 
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Figure 112 Cartoon model  of snRNP particle assembly.  The assembly 
pathway of the snRNP core particle in the cytoplasm and of the UI 
and U2 snRNP specific proteins is based on the data in this manu- 
script and in Feeney et al. (1989) and Sauterer et al. (1990). 
Previous studies demonstrated that snRNP core proteins 
are stored in the cytoplasm in large pools of partially assem- 
bled  intermediates (Sauterer et al.,  1988;  Feeney et al., 
1989).  SnRNP core assembly occurs when newly synthe- 
sized snRNAs appear  in the cytoplasm immediately after 
synthesis before returning permanently to the interphase nu- 
cleus  (Fig.  10). This  suggests  that  some  of the  snRNP- 
specific proteins may also assemble with the snRNP parti- 
cles in the cytoplasm immediately after translation and move 
back into the nucleus with the newly assembled snRNP core 
particles.  Several  results  suggest that this is possible  for 
some but not all of the snRNP-specific proteins. 
The A, C, and ,g proteins move into the nucleus indepen- 
dently of snRNP assembly. If snRNP particle assembly is in- 
hibited by blocking the synthesis of new snRNAs with acti- 
nomycin D, newly synthesized A, C, and//proteins continue 
to  move into  the  nucleus and assemble  with preexisting 
snRNP particles (Feeney et al.,  1989).  This demonstrates 
that these proteins can enter the nucleus independently and 
that the nuclear pools are in a dynamic equilibrium with the 
existing stable nuclear snRNPs. However, it does not elimi- 
nate the possibility that some of these proteins can also asso- 
ciate with newly assembled snRNPs that they encounter in 
the cytoplasm. 
The nuclear accumulation of the snRNP-specific proteins 
in the absence of snRNP assembly suggests that these pro- 
teins have independent nuclear localization signals.  A  va- 
riety of studies have demonstrated that the nuclear accumu- 
lation of specific proteins is the result of a short sequence 
motif known as a nuclear localization signal (NLS) (Ding- 
wall and Laskey, 1986).  Studies on a variety of cellular and 
viral proteins indicate that NLS are heterogeneous although 
they are usually a combination of  basic and hydrophobic resi- 
dues  and  several  additional factors  affect its  activity in- 
cluding localization in the protein and cooperation between 
multiple NLS (Roberts et al., 1987; Dingwall et al., 1988). 
The SV-40 large T antigen NLS is considered a canonical 
NLS and has a minimum sequence of  pro-lys-lys-lys-arg-lys- 
val (Dingwall and Laskey, 1986). Analysis of the primary se- 
quences of the U1- and U2-specific proteins deduced from 
cDNA cloning identifies sequence motifs that are putative 
NLS in the Ul-specific A (arg~o7 glu lys arg lys pro lys) and 
70-kD protein (arg2s8 lys arg arg ser ser arg ser arg) and in 
the U2-specific h/(lys~gj lys lys gly gly pro ser pro) and B" 
(lysj03 lys lys glu lys lys lys ala lys thr val) proteins. The B" 
NLS is the closest to that of SV-40 large T antigen. Genetic 
analysis of the proteins will be required to determine if these 
are functional NLS. 
The newly assembled U2 snRNP is immunoprecipitated 
from cytoplasts by an antiserum that recognizes the  U2- 
specific ,~ and B" proteins and by antiserum directed against 
the core proteins. The precipitated particles include newly 
assembled snRNPs containing the U2 snRNA precursor U2', 
which is ~12 nt larger than U2 at the 3' end. The extra nucle- 
otides are removed in the cytoplasm after snRNP assembly 
(Zieve et al., 1988). A small fraction of the B" protein is also 
found sedimenting in ll-13S snRNP particles in the cyto- 
plast fraction. This demonstrates that at least one of the U2- 
specific proteins,  the  B" protein,  assembles  with the  U2 
snRNP particle in the cytoplasm early in the maturation se- 
quence. Although both immunoprecipitation analysis and di- 
rect analysis on two-dimensional gels demonstrates that the 
vast majority of B" protein is assembled into snRNP particles 
in the nucleus, small amounts of pulse-labeled B" are found 
in cytoplasmic fractions (Sauterer et al.,  1990;  Feeney et 
al.,  1989).  This is consistent with the hypothesis that the 
B" protein assembles with the U2 snRNP in the cytoplasm 
immediately after translation. The absence of an unassem- 
bled pool of this protein is also consistent with the observa- 
tion that the maturation and nuclear accumulation of the U2 
snRNP is more sensitive to the inhibition of  protein synthesis 
than the U1 snRNP particle. After a 1-h inhibition of protein 
synthesis the U2 snRNA accumulates in the cytoplasm as 
U2' while U1  snRNP assembly and nuclear accumulation 
continues (Zieve,  1987).  If the arrest of U2 maturation is 
correlated with the absence of the B" protein, this suggests 
that B" is involved in the final maturation of the U2 snRNA. 
Analysis of mutant U2  snRNAs that do not bind the U2 
specific proteins in Xenopus oocytes suggests the U2 specific 
proteins are not necessary for either the hypermethylation  of 
the 5' cap or the nuclear accumulation of the U2  snRNP 
(Mattaj and De Robertis, 1985; Mattaj, 1986). However,  in 
yeast, mutations in the U2-specific protein binding sites re- 
suited in U2 RNAs with improperly terminated 3' ends and 
significantly lowered  growth  rates  (Shuster  and  Guthrie, 
1988). 
Both  immunoprecipitates of the  [32P]phosphate-labeled 
70-kD Ul-specific protein and immunoblots fail to detect any 
70-kD protein in cytoplasmic fractions prepared by aqueous 
fractionation or cell enucleation. In addition, newly synthe- 
sized U1 snRNA can be immunoprecipitated from the cyto- 
plasm by antisera to the core proteins but not by a mono- 
clonal antiserum to the 70-kD  protein.  This suggests the 
70-kD Ul-specific protein enters the nucleus independently 
of U1 snRNP assembly. 
The presence of the A, C, and ,g snRNP proteins in forms 
that are not immunoprecipitated with the snRNP particles 
suggests that they are either in unassembled pools in vivo or 
have been eluted from the snRNP particles during the isola- 
tion procedure. Several results suggest that they are not from 
disassembled  particles.  The  immunoprecipitated  snRNP 
particles are stable and retain the identical protein compo- 
sition in buffers up to 0.5 M NaCI (Sauterer et al.,  1990). 
The stoichiometry of these particles, calculated from ratios 
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composition of the proteins, suggests there are two copies of 
the A and C proteins per U1 snRNP (Feeney et al.,  1989). 
It appears unlikely that the substantial  pools of A, C, and .~ 
proteins are  all quantitatively  assembled  into snRNP par- 
ticles.  Although  there  are  possible  differences  in the  im- 
munoprecipitation  efficiencies of unassembled  proteins  in 
cytoplasmic  fractions  and  assembled  particles  in  nuclear 
fractions,  comparison  of immunoprecipitated  cytoplasmic 
and nuclear fractions and two-dimensional gels of total cyto- 
plasmic and nuclear fractions suggest that while the unas- 
sembled pools of the Ul-specific A and C proteins are of al- 
most equal  size to the assembled  pools,  the unassembled 
pool of the U2-specific ,~/protein is substantially  larger than 
the assembled pool (Feeney et al.,  1989). 
The available  sequence data have identified two different 
functional domains in the U1- and U2-specific proteins. The 
70-kD, A, and B" proteins (but not the C or ,n/ proteins) have 
a sequence motif identified in a large family of proteins that 
bind RNA or single-stranded DNA known as the RNA bind- 
ing  domain.  This  domain  is often  80-90  amino  acids  in 
length  and included in it is an eight amino acid motif, the 
RNP consensus, which is more highly conserved (Swanson 
et al.,  1987; Mattaj,  1989; Bell et al.,  1988).  The A and B" 
snRNP proteins both have two copies of the RNA binding 
domain. In fact, there is extensive homology between the U1- 
specific A  and the U2-specific B" proteins and several  an- 
tisera cross-react with the two proteins. However, our data 
indicate  these  proteins  have  different assembly  strategies 
with the A protein but not the B" protein present in unassem- 
bled pools.  The 70-kD protein has only one RNA binding 
domain and deletion analysis suggests that almost the entire 
domain is necessary for the specific interaction  of the 70-kD 
protein with the first stem loop of the U1 snRNA (Query et 
al., 1989).  However, the 70-kD protein also has a sequence 
motif found in two Drosophila proteins that regulate alterna- 
tive  pre-mRNA  splicing  (Bell  et al.,  1988;  Query  et al., 
1989;  Mattaj,  1989).  This motif is a highly charged set of 
amino acids near the COOH terminus of the 70-kD protein. 
The Drosophila proteins also contain the RNP consensus se- 
quence in addition to the highly charged region and it is pos- 
tulated  that the charged regions function through  protein- 
protein interactions (Mattaj,  1989;  Bingham et al.,  1988). 
The similarity between the Drosophila proteins and the 70- 
kD protein suggests that the 70-kD protein may also have a 
role in the regulation of pre-mRNA processing. Further stud- 
ies will be needed to determine the contributions of these 
motifs to the sequence specific interaction of the snRNP pro- 
teins with the snRNAs and possibly  with their processing 
substrates. 
The snRNP particles are stable components of the inter- 
phase nucleus. While the U1 snRNP particle is as stable as 
ribosomes the U2 snRNP turns over with a half-life of about 
two cell generations (Sauterer  et al.,  1988).  Within the nu- 
cleus the particles function in repeated rounds of pre-mRNA 
splicing. The observation that the U1 specific A and C and 
the U2-specific g  proteins are in pools that exchange with 
stable snRNPs,  and that the Ul-specific 70-kD protein has 
homologies to other proteins that regulate pre-mRNA splic- 
ing, opens the possibility that these proteins can regulate the 
function of the U1  and  U2 snRNPs in nuclear pre-mRNA 
splicing.  Experiments are underway  to test the hypothesis 
that the A, C, and .g proteins dissociate from the snRNP par- 
ticles during  pre-mRNA splicing. 
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